During the past decade, University of Michigan - Brighton Center for Specialty Care conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Michigan - Brighton Center for Specialty Care" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "NRG Oncology" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan - Brighton Center for Specialty Care" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan - Brighton Center for Specialty Care" are "Anal Basaloid Carcinoma" (2 trials), "Anal Canal Cloacogenic Carcinoma" (2 trials), "Anal Margin Squamous Cell Carcinoma" (2 trials), "Malignant Solid Neoplasm" (2 trials) and "Acinar Cell Carcinoma" (1 trials). Many other conditions were trialed in "University of Michigan - Brighton Center for Specialty Care" in a lesser frequency.

Most popular intervention types in "University of Michigan - Brighton Center for Specialty Care" are "Drug" (10 trials), "Other" (7 trials), "Procedure" (7 trials), "Biological" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (6 trials), "Biospecimen Collection" (5 trials), "Computed Tomography" (4 trials), "Magnetic Resonance Imaging" (4 trials) and "Questionnaire Administration" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan - Brighton Center for Specialty Care" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Michigan - Brighton Center for Specialty Care". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Michigan - Brighton Center for Specialty Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan - Brighton Center for Specialty Care, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".